Minimum concentrations of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block.
D002800:Cholinesterase Inhibitors; D006898:Hydroxylamines / Q000494:pharmacology*; D007306:Insecticides / Q000633:toxicity*; D008697:Methane; D019148:Neuromuscular Blockade; D009469:Neuromuscular Junction / Q000494:pharmacology*; D010091:Oximes; D011725:Pyridines / Q000494:pharmacology*; D011726:Pyridinium Compounds
D002800:Cholinesterase Inhibitors; D006898:Hydroxylamines; D007306:Insecticides; D010091:Oximes; D011725:Pyridines; D011726:Pyridinium Compounds; C014677:1-methylpyridinium; C023728:acetaldehyde oxime; D008697:Methane
CHOLINESTERASE/antagonists; HYDROXYLAMINES/pharmacology; INSECTICIDES/toxicology; MYONEURAL JUNCTION/pharmacology; PYRIDINES/pharmacology